An international collaborative (AIEOP-BFM [Associazione Italiana Ematologia Oncologia Pediatrica - Berlin-Franklin-Munster]) treatment protocol for children and adolescents with Acute Lymphoblastic Leukaemia
Phase 3
Active, not recruiting
- Conditions
- Acute lymphoblastic leukemiaCancer - Leukaemia - Acute leukaemiaCancer - Children's - Leukaemia & Lymphoma
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 6178
Inclusion Criteria
Patients meeting all:
- newly diagnosed acute lymphoblastic leukemia
- no Ph+ (BCR/ABL or t(9;22)-positive) ALL
- no evidence of pregnancy or lactation period
- no participation in another study
- patient enrolled in participating centre
- written informed consent
Exclusion Criteria
Patients meeting any of the following will not be eligible and will be analysed seperately:
- pre-treatment with cytostatic drugs
- steroid pre-treatment with >/= 1mg/kg/d for more than two weeks during the last month before diagnosis
- treatment started according to another protocol
- underlying diseases that prohibit treatment according to the protocol
- ALL diagnosed as second malignancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method